Center for Genetic Engineering and Biotechnology
{{Short description|State-owned biotechnology institute in Cuba}}
{{Infobox government agency
| name = Center for Genetic Engineering and Biotechnology
| native_name =
| native_name_a =
| native_name_r =
| type = Research institute
| seal =
| seal_size =
| seal_caption =
| seal_alt =
| logo =
| logo_size =
| logo_caption =
| logo_alt =
| image = Visita al Centro de Ingeniería Genética y Biotecnología - 17545422613.jpg
| image_size =
| image_caption = Offices of the CIGB
| image_alt =
| formed = {{Start date|1985|07|01}}
| preceding1 =
| preceding2 =
| dissolved =
| superseding1 =
| superseding2 =
| agency_type =
| jurisdiction = {{CUB}}
| status =
| headquarters = Avenida 31 No. 15802, Havana, Cuba
| coordinates = {{coord|23.0738|-82.4523|display=inline,title}}
| motto =
| employees =
| budget =
| minister_type =
| minister1_name =
| minister1_pfo =
| minister2_name =
| minister2_pfo =
| deputyminister_type =
| deputyminister1_name =
| deputyminister1_pfo =
| deputyminister2_name =
| deputyminister2_pfo =
| chief1_name =
| chief1_position =
| chief2_name =
| chief2_position =
| parent_department =
| parent_agency =
| parent_agency_type =
| child1_agency =
| child2_agency =
| keydocument1 =
| website = {{URL|www.cigb.edu.cu}}
| agency_id =
| map =
| map_size =
| map_caption =
| map_alt =
| footnotes =
| embed =
}}
The Center for Genetic Engineering and Biotechnology ({{langx|es|Centro de Ingeniería Genética y Biotecnología}}, CIGB) is a research institute in Havana, Cuba.
Founding
In 1982, the United Nations Industrial Development Organization (UNIDO) offered grant funding via a competitive application process to facilitate biotechnology development in the Third World.{{Rp|page=132}} Cuba sought, but did not receive funding, which instead was awarded to a joint project proposed by India and Italy.{{Rp|page=132}} Cuba nonetheless proceeded with the development of a biotechnology research institution using its own funds, CIGB.{{Rp|page=132}}
Activity
In 2006, CIGB developed the Heberprot-P, which is used to treat foot ulcers.{{Cite web |title=UA Health Sciences Researchers Look to Collaborate With Cuba on Diabetic Wound Therapy {{!}} Department of Medicine |url=https://deptmedicine.arizona.edu/news/2016/ua-health-sciences-researchers-look-collaborate-cuba-diabetic-wound-therapy |access-date=2023-12-27 |website=deptmedicine.arizona.edu}} Its use results in rapid wound healing and a 75% decrease in amputations among diabetics with foot ulcers.
As of 2017, CIGB had 1,600 employees and sold 21 products internationally.{{Rp|page=138}}
As of 2020, CIGB had two joint ventures with China.{{Cite book |last=Yaffe |first=Helen |title=We Are Cuba! How a Revolutionary People Have Survived in a Post-Soviet World |date=2020 |publisher=Yale University Press |isbn=978-0-300-23003-1 |edition=hardcover |location=USA}}{{Rp|page=143}}
It is responsible for creating the Abdala vaccine.{{Cite web|title=Cuba's COVID vaccine rivals BioNTech-Pfizer, Moderna |date=2021-06-27|url=https://www.dw.com/en/cubas-covid-vaccine-rivals-biontech-pfizer-moderna/a-58052365|access-date=2021-06-28|website=DW.COM|language=en-GB}}{{cite web |title=ABDALA Clinical Study - Phase III |url=https://rpcec.sld.cu/en/trials/RPCEC00000359-En |website=rpcec.sld.cu |publisher=Registro Público Cubano de Ensayos Clínicos |access-date=March 22, 2021 |url-status=live|archive-url=https://web.archive.org/web/20210320062328/https://rpcec.sld.cu/en/trials/RPCEC00000359-En |archive-date=2021-03-20 }}{{cite web |title=ABDALA Clinical Study |url=https://rpcec.sld.cu/en/trials/RPCEC00000346-En |website=rpcec.sld.cu |publisher=Registro Público Cubano de Ensayos Clínicos |access-date=March 22, 2021 |url-status=live|archive-url=https://web.archive.org/web/20210122072416/https://rpcec.sld.cu/en/trials/RPCEC00000346-En |archive-date=2021-01-22 }}
The Centre developed the COVID-19 vaccine Mambisa, which is in the final stages of clinical trials.{{cite web |last1=Sánchez |first1=Liz Conde |title=How is Mambisa progressing on the road to authorization as an anti-COVID-19 vaccine? |url=https://en.granma.cu/cuba/2022-04-07/how-is-mambisa-progressing-on-the-road-to-authorization-as-an-anti-covid-19-vaccine |website=en.granma.cu |access-date=6 May 2022 |language=en |date=7 April 2022}}
See also
References
{{reflist}}
External links
- {{official website}}
{{authority control}}
Category:Medical research institutes in Cuba
Category:Research institutes established in 1985
Category:COVID-19 vaccine producers
{{med-company-stub}}
{{cuba-stub}}